---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-142037"
form_type: "8-K/A"
ticker: "FATE"
cik: "0001434316"
company_name: "FATE THERAPEUTICS INC"
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:30:47.854318+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Fate Therapeutics board sets annual say-on-pay votes after stockholder advisory approval

## Summary
- Stockholders approved advisory vote on executive compensation every one year.
- Board determined to hold non-binding say-on-pay votes annually.
- Next frequency vote required no later than 2031 annual meeting.
- No other changes from original May 30, 2025 8-K reported.

## SEC filing metadata
- accession: 0001193125-25-142037
- form_type: 8-K/A
- ticker: FATE
- cik: 0001434316
- company_name: FATE THERAPEUTICS INC
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434316/000119312525142037/0001193125-25-142037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434316/000119312525142037/d35713d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-142037
- JSON: https://secwatch.observer/filing/0001193125-25-142037.json
- Plain text: https://secwatch.observer/filing/0001193125-25-142037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.